Exchange: NASDAQ·Updated 11:47 AM EDT
BTAI logo

BTAI BioXcel Therapeutics Inc

$0.06
$0.002
(3.45%)
Today
Reported EarningsMay 15
Mkt Cap$1.82M
Vol158,305.00

About BTAI

BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.
38

Bearish Sentiment

How do you feel about BTAI?

Ozymandias_
$BTAI Hard to believe this company went bankrupt with an FDA drug approved and another approval in the pipeline. Management should never be allowed to run another company.
2
13
bdkrma
$BTAI no point in doing anything at this point. May as well let shares dissolve? Holding strong for a miracle, or dissolution and a tax loss.
9
aaron03
$BTAI Congratulations to the worst CEO in biotech Vimal Mehta. This idiot couldn't get $BTAI to what I believe would have been approved by the FDA for acute agitation associated with bipolar disorders or schizophrenia in at home setting in November. Talk about a complete mismanagement of resources. Literally 2 months away.
8
CaptainCihan
$BTAI $BTAI — Serious question for anyone following the Oaktree situation closely: Why do you think these debt deadlines keep getting extended by just 3–5 days at a time? If Oaktree believed there was no viable solution and simply wanted to enforce its rights against the company/assets, why keep agreeing to these very short extensions? Could these repeated short extensions suggest that both sides are waiting for something specific to be finalized — a strategic deal, financing, partnership, asset sale, or another transaction? Curious to hear different interpretations. What do you think is actually happening behind the scenes?
8
YoSoyY0
$BTAI Buying 3000 more and lowering my average; now without the pressure from the Nasdaq it's recovering; as soon as there's any news it will skyrocket, let's go!
7
PrinceofParabolic
$BTAI thank God for metals and miners, I'm done doing spec bets on biotechs. Cash poor companies with bad management teams and a corrupt FDA
7
Stockinvestor73
$BTAI somebosy needs to contact stocktwits and tell them it has transferred to the otc and trades under btaiQ
6
WhatPenguin
$BTAI wondering if they even tried to sell the company. The thought probably never occurred to the ever so business savvy idiots.
6
J_machete
$BTAI I could see a bidding war happening... There have to be parties wanting this potential blockbuster
6
SrTxan
$BTAI Here’s my Sunday table. Apparently, financial analysis isn’t that difficult after all. Disclaimer: Price ranges calculated using the highly respected "pick a random percentage and put it in a table" valuation method. These are not price targets.
1
3
wndyctyboy1975
$BTAI the whole time I was buying down all I was doing was giving Crooks money we were all swindled on the false hope that something good was going to come of this instead they file bankruptcy stole our money and ran away with it
5
TwongStocks
$BTAI FINRA confirms that BTAI will shift to OTC, effective Sept 8. New ticker on OTC will be BTAIQ.
5
sagasta29
$BTAI the market doesn’t understand today’s move, it is a clear signal that fda november is coming and they are going to wait
1
2
SrTxan
$BTAI That’s exactly what your life needs: someone to take control of you through a distressed-debt conversion… into a bull.
1
2
TwongStocks
$BTAI SEC filing this morning. Under Item 3.01, they disclose NASDAQ will delist them. Trading will be suspended by NASDAQ at the open on Sept 8 and BTAI is expected to shift to the OTC Pink Sheets. BTAI does not intend to appeal. https://www.sec.gov/ix?doc=/Archives/edgar/data/1720893/000110465926104106/tm2624539d1_8k.htm
4
SrTxan
$BTAI Here’s another interesting comparison: When Teva agreed to acquire Emalex Biosciences for $700M upfront + up to $200M in additional milestones, ecopipam was NOT FDA approved. It was an investigational neuroscience asset with a completed Phase 3 trial and was described as NDA ready. In fact, Teva didn’t submit the NDA until after the acquisition closed. Now Teva is offering $57.5M upfront as the stalking-horse bid for substantially all of BTAI’s assets, including IGALMI, a drug that is already FDA-approved for its current indication, with an additional at home indication under FDA review. Does that mean IGALMI is worth $700M? Of course not. Different assets, different markets, different circumstances. But does it make $57.5M an interesting starting floor for an auction? Absolutely.
1
1
Placebo73
$BTAI Well, 100$ a share with the FDA product?? Really?? Stupid posts with AI usage.......so lame from many guys here, that vanished misteriouly.........And this CEO should go straight to jail. A partneship with a major, would have cut dilution and finantial effort by a mile. But no, doing everything alone its better, and screw shareholders is fun. Hope he gets terminal cancer.
4
KR33P
$BTAI oh look they filed and i don't give a damn it's like i only used money id whipe my ass with either way 😂. Could be a squeeze play. Could go to zero. Lesson is don't buy stocks with money you care about.
4
YoSoyY0
$BTAI Up up up! Nasdaq is a cancer. Let's get back above a dollar, but without any requirement or obligation.
3
Ashmitch20
$BTAI Bought a small piece yesterday. If it doesnt jump a little at the open I’m getting out.
1

Advertisement|Remove ads.